ArticleComputational and structural biotechnology journal2026
The potential of deep learning on the discovery of new genes implicated in differences of sex development.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite advances in understanding genetic causes of DSD (differences of sex development), the molecular cause remains unknown for over half of affected individuals. Next-generation sequencing (NGS) has improved diagnosis, but interpreting results can be challenging, especially when no known DSD gene mutations are found, or only variants of unknown significance appear. Identifying new genes involved in sex development from whole exome sequencing (WES) alone is difficult. To overcome this, we introduce "GONAD-ResNet," a residual convolutional neural network designed to predict novel DSD-associated genes by learning complex patterns in time-dependent single-cell gene expression data. When applied to WES data from six patients (three XX, three XY) with DSD, GONAD-ResNet prioritized genes with expression profiles similar to known DSD genes while disregarding ubiquitous or irrelevant genes. This narrowed the list of potential candidates from around 1000 to a few promising novel genes per patient. This innovative approach accelerates the discovery of new DSD-related genes, opening new research avenues and potentially improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.